company background image
RHY logo

Rhythm Biosciences ASX:RHY Stock Report

Last Price

AU$0.095

Market Cap

AU$23.4m

7D

-5.0%

1Y

-79.8%

Updated

28 Mar, 2024

Data

Company Financials

Rhythm Biosciences Limited

ASX:RHY Stock Report

Market Cap: AU$23.4m

RHY Stock Overview

Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally.

RHY fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rhythm Biosciences Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rhythm Biosciences
Historical stock prices
Current Share PriceAU$0.095
52 Week HighAU$0.83
52 Week LowAU$0.091
Beta2.72
1 Month Change-5.00%
3 Month Change-29.63%
1 Year Change-79.79%
3 Year Change-91.91%
5 Year Change-36.67%
Change since IPO-70.77%

Recent News & Updates

Recent updates

Is Rhythm Biosciences (ASX:RHY) In A Good Position To Deliver On Growth Plans?

Dec 06
Is Rhythm Biosciences (ASX:RHY) In A Good Position To Deliver On Growth Plans?

We're Not Very Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Rate

Aug 09
We're Not Very Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Rate

We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Apr 11
We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

Dec 02
Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Jul 19
We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely

Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

Mar 03
Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation

Do Institutions Own Rhythm Biosciences Limited (ASX:RHY) Shares?

Dec 03
Do Institutions Own Rhythm Biosciences Limited (ASX:RHY) Shares?

Shareholder Returns

RHYAU HealthcareAU Market
7D-5.0%4.1%1.3%
1Y-79.8%-13.5%11.5%

Return vs Industry: RHY underperformed the Australian Healthcare industry which returned -13.6% over the past year.

Return vs Market: RHY underperformed the Australian Market which returned 11.6% over the past year.

Price Volatility

Is RHY's price volatile compared to industry and market?
RHY volatility
RHY Average Weekly Movement16.6%
Healthcare Industry Average Movement6.8%
Market Average Movement8.8%
10% most volatile stocks in AU Market17.1%
10% least volatile stocks in AU Market3.2%

Stable Share Price: RHY's share price has been volatile over the past 3 months.

Volatility Over Time: RHY's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Australian stocks.

About the Company

FoundedEmployeesCEOWebsite
2017n/an/ahttps://www.rhythmbio.com

Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Rhythm Biosciences Limited Fundamentals Summary

How do Rhythm Biosciences's earnings and revenue compare to its market cap?
RHY fundamental statistics
Market capAU$23.37m
Earnings (TTM)-AU$8.63m
Revenue (TTM)AU$2.07m

11.3x

P/S Ratio

-2.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RHY income statement (TTM)
RevenueAU$2.07m
Cost of RevenueAU$2.04m
Gross ProfitAU$27.30k
Other ExpensesAU$8.66m
Earnings-AU$8.63m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.035
Gross Margin1.32%
Net Profit Margin-417.89%
Debt/Equity Ratio0%

How did RHY perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.